Alzheimers Dement

1. SCHINDLER SE, Li Y, Li M, Despotis A, et al
   Using Alzheimer's disease blood tests to accelerate clinical trial enrollment.
   Alzheimers Dement. 2022 Aug 7. doi: 10.1002/alz.12754.
   

   >> Share

   
   
2. OLCHANSKI N, Daly AT, Zhu Y, Breslau R, et al
   Alzheimer's disease medication use and adherence patterns by race and ethnicity.
   Alzheimers Dement. 2022 Aug 8. doi: 10.1002/alz.12753.
   

   >> Share

   
   
3. LANGBAUM JB, Zissimopoulos J, Au R, Bose N, et al
   Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
   Alzheimers Dement. 2022 Aug 10. doi: 10.1002/alz.12737.
   

   >> Share

   
   
4. PALMQVIST S, Stomrud E, Cullen N, Janelidze S, et al
   An accurate fully automated panel of plasma biomarkers for Alzheimer's disease.
   Alzheimers Dement. 2022 Aug 11. doi: 10.1002/alz.12751.
   

   >> Share

   
   

   
   Biol Psychiatry

5. MA YH, Chen HS, Liu C, Feng QS, et al
   Association of Long-term Exposure to Ambient Air Pollution With Cognitive Decline and Alzheimer's Disease-Related Amyloidosis.
   Biol Psychiatry. 2022 May 18. pii: S0006-3223(22)01255.
   

   >> Share

   
   

   
   BMC Geriatr

6. INSKIP MJ, Mavros Y, Sachdev PS, Hausdorff JM, et al
   Promoting independence in Lewy body dementia through exercise: the PRIDE study.
   BMC Geriatr. 2022;22:650.
   

   >> Share

   
   

   
   Brain

7. COURSE MM, Gudsnuk K, Keene CD, Bird TD, et al
   Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
   Brain. 2022 Aug 11. pii: 6660735. doi: 10.1093.
   

   >> Share

   
   

   
   Exp Neurol

8. GOMES P, Tzouanou F, Skolariki K, Iakovou AV, et al
   Extracellular vesicles and Alzheimer's disease in the novel era of Precision Medicine: Implications for disease progression, diagnosis and treatment.
   Exp Neurol. 2022 Aug 8:114183. doi: 10.1016/j.expneurol.2022.114183.
   

   >> Share

   
   

   
   J Alzheimers Dis

9. STOILJKOVIC M, Gutierrez KO, Kelley C, Horvath TL, et al
   TREM2 Deficiency Disrupts Network Oscillations Leading to Epileptic Activity and Aggravates Amyloid-beta-Related Hippocampal Pathophysiology in Mice.
   J Alzheimers Dis. 2022;88:837-847.
   

   >> Share

   
   
10. MABROUK R, Gotkiewicz M, Rauramaa T, Tanila H, et al
    DAPI (4',6-diamidino-2-phenylindole) Stains Compact Amyloid Plaques.
    J Alzheimers Dis. 2022;88:949-955.
    

    >> Share

    
    
11. LORETO F, Fitzgerald A, Golemme M, Gunning S, et al
    Prevalence of Depressive Symptoms in a Memory Clinic Cohort: A Retrospective Study.
    J Alzheimers Dis. 2022;88:1179-1187.
    

    >> Share

    
    
12. NOVOTNY JS, Gonzalez-Rivas JP, Vassilaki M, Krell-Roesch J, et al
    Natural Pattern of Cognitive Aging.
    J Alzheimers Dis. 2022;88:1147-1155.
    

    >> Share

    
    
13. AGUILAR-CALVO P, Sevillano AM, Rasool S, Cao KJ, et al
    Noninvasive Antemortem Detection of Retinal Prions by a Fluorescent Tracer.
    J Alzheimers Dis. 2022;88:1137-1145.
    

    >> Share

    
    
14. CANARIO E, Chen D, Han Y, Niu H, et al
    Global Network Analysis of Alzheimer's Disease with Minimum Spanning Trees.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD215573. doi: 10.3233/JAD-215573.
    

    >> Share

    
    
15. PEREZ SD, Phillips JS, Norise C, Kinney NG, et al
    Neuropsychological and Neuroanatomical Features of Patients with Behavioral/Dysexecutive Variant Alzheimer's disease (AD): A Comparison to Behavioral Variant Frontotemporal Dementia and Amnestic AD Groups.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD215728. doi: 10.3233/JAD-215728.
    

    >> Share

    
    
16. HOFFMANN CM, Nianogo RA, Yaffe K, Rosenwohl-Mack A, et al
    Importance of Accounting for Regional Differences in Modifiable Risk Factors for Alzheimer's Disease and Related Dementias: The Case for Tailored Interventions.
    J Alzheimers Dis. 2022 Jul 30. pii: JAD220278. doi: 10.3233/JAD-220278.
    

    >> Share

    
    
17. SOARES JZ, Valeur J, Saltyte Benth J, Knapskog AB, et al
    Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD220407. doi: 10.3233/JAD-220407.
    

    >> Share

    
    
18. TAHAMI MONFARED AA, Stern Y, Doogan S, Irizarry M, et al
    Stakeholder Insights in Alzheimer's Disease: Natural Language Processing of Social Media Conversations.
    J Alzheimers Dis. 2022 Jul 30. pii: JAD220422. doi: 10.3233/JAD-220422.
    

    >> Share

    
    

    
    J Neurochem

19. GALGANI A, Vergallo A, Campese N, Lombardo F, et al
    Biological determinants of blood-based cytokines in the Alzheimer's Disease clinical continuum.
    J Neurochem. 2022 Aug 11. doi: 10.1111/jnc.15686.
    

    >> Share

    
    
20. DEVINA T, Wong YH, Hsiao CW, Li YJ, et al
    Endoplasmic reticulum stress induces Alzheimer's disease-like phenotypes in the neuron derived from the induced pluripotent stem cell with D678H mutation on amyloid precursor protein.
    J Neurochem. 2022 Aug 9. doi: 10.1111/jnc.15687.
    

    >> Share

    
    

    
    J Neurol

21. ALTUNA M, Larumbe R, Zelaya MV, Moreno S, et al
    Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization.
    J Neurol. 2022;269:4853-4862.
    

    >> Share

    
    
22. RHODUS EK, Barber J, Kryscio RJ, Abner EL, et al
    Frontotemporal neurofibrillary tangles and cerebrovascular lesions are associated with autism spectrum behaviors in late-life dementia.
    J Neurol. 2022;269:5105-5113.
    

    >> Share

    
    
23. ACHENBACH J, Faissner S, Saft C
    Resurrection of sildenafil: potential for Huntington's Disease, too?
    J Neurol. 2022;269:5144-5150.
    

    >> Share

    
    

    
    J Neurol Neurosurg Psychiatry

24. O'CONNOR A, Abel E, Benedet AL, Poole T, et al
    Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
    J Neurol Neurosurg Psychiatry. 2022 Aug 10. pii: jnnp-2022-329663.
    

    >> Share

    
    
25. BARBA L, Abu Rumeileh S, Bellomo G, Paolini Paoletti F, et al
    Cerebrospinal fluid beta-synuclein as a synaptic biomarker for preclinical Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2022 Aug 9. pii: jnnp-2022-329124.
    

    >> Share

    
    

    
    J Neurosci

26. GUO T, Pan X, Jiang G, Zhang D, et al
    Downregulating PTBP1 fails to convert astrocytes into hippocampal neurons and to alleviate symptoms in Alzheimer's mouse models.
    J Neurosci. 2022 Aug 9. pii: JNEUROSCI.1060-22.2022.
    

    >> Share

    
    

    
    JAMA

27. DEPEW R
    To My Husband With Alzheimer Disease.
    JAMA. 2022;328:587.
    

    >> Share

    
    

    
    Nat Med

28. MILA-ALOMA M, Ashton NJ, Shekari M, Salvado G, et al
    Plasma p-tau231 and p-tau217 as state markers of amyloid-beta pathology in preclinical Alzheimer's disease.
    Nat Med. 2022 Aug 11. pii: 10.1038/s41591-022-01925.
    

    >> Share

    
    

    
    Nat Rev Neurol

29. PANZA F, Lozupone M
    The challenges of anti-tau therapeutics in Alzheimer disease.
    Nat Rev Neurol. 2022 Aug 8. pii: 10.1038/s41582-022-00702.
    

    >> Share

    
    

    
    Nervenarzt

30. FROLICH L, Hausner L
    [Erratum to: Disease-modifying treatment approaches for Alzheimer's disease].
    Nervenarzt. 2022 Aug 12. pii: 10.1007/s00115-022-01366.
    

    >> Share

    
    

    
    Neurobiol Aging

31. GRAFF-RADFORD J, Mielke MM, Hofrenning EI, Kouri N, et al
    Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease.
    Neurobiol Aging. 2022;119:1-7.
    

    >> Share

    
    

    
    Neurochem Res

32. LUO JS, Ning JQ, Chen ZY, Li WJ, et al
    The Role of Mitochondrial Quality Control in Cognitive Dysfunction in Diabetes.
    Neurochem Res. 2022;47:2158-2172.
    

    >> Share

    
    
33. WANG X, Li B, Yu X, Zhou Y, et al
    The Neuroprotective Effect of GM-1 Ganglioside on the Amyloid-Beta-Induced Oxidative Stress in PC-12 Cells Mediated by Nrf-2/ARE Signaling Pathway.
    Neurochem Res. 2022;47:2405-2415.
    

    >> Share

    
    
34. IBI D, Kondo S, Ohmi A, Kojima Y, et al
    Preventive Effect of Betaine Against Cognitive Impairments in Amyloid beta Peptide-Injected Mice Through Sirtuin1 in Hippocampus.
    Neurochem Res. 2022;47:2333-2344.
    

    >> Share

    
    

    
    Neurologia (Engl Ed)

35. PUIG-PIJOAN A, Garcia-Escobar G, Fernandez-Lebrero A, Manero Borras RM, et al
    The CORCOBIA study: Cut-off points of Alzheimer's disease CSF biomarkers in a clinical cohort.
    Neurologia (Engl Ed). 2022 Aug 9. pii: S2173-5808(22)00084.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share